We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Medison Recognized for Growth Leadership in Europe

By MedImaging staff writers
Posted on 09 Apr 2007
Print article
Medison Co., Ltd. (Seoul, Korea), an industry-leading manufacturer of specialized diagnostic ultrasound systems, announced that the company has won the 2007 Frost & Sullivan Competitive Strategy Leadership Award in March 2007 in recognition of its strategic initiatives to establish itself as a leading enterprise in the European ultrasound market.

The award is presented each year to a company whose competitive strategy has yielded significant gains in market share during the research period.
"Medison has accomplished high growth in the world's biggest and most advanced market, Europe, by aggressive strategies and customer-oriented management,” said Karthik Arun B, head analyst from the Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company. "Especially it showed great accomplishment in the high-end 3D [three-dimensional] ultrasound system,” he added.

The company implemented an aggressive strategy to achieve a significant market share, especially in the high-end 3D ultrasound segment across Europe. Medison commands a market share of almost 40% in the high-end 3D and 4D ultrasound segment in Europe in 2006.

"Medison ultrasound systems are acknowledged for their superior quality and highly competitive prices. We believe this award reflects that,” said Jae-Bum Choi, CEO, Medison, "We will build on this foundation to globalize the company by creating a system of local headquarters.”

Eighty-five percent of Medison's sales come from exports. It has global networks all over the world. The company has 10 overseas subsidiaries and 100 agencies in 90 countries. The local headquarters system will be introduced gradually by 2010. As a first step, Medison has established a European headquarters in Hoofddorp, the Netherlands in 2006.

Medison has emerged as a very important participant in the ultrasound market. The company has been successful in a market dominated by established multi-modality vendors. It has an aggressive pricing strategy and provides a top-of-the-line product range at highly competitive prices.

Medison, also winner of the Frost & Sullivan Product Differentiation & Innovation Award in 2001, was recognized as ‘The Highest Growth Rate Enterprise' by the ultrasound system market report ‘Klein Report' in 2004, recording a 94% growth rate in the U.S. market.


Related Links:
Medison
Frost & Sullivan
Radiology Software
DxWorks
New
High-Precision QA Tool
DEXA Phantom
Digital X-Ray Detector Panel
Acuity G4
New
Mammography System (Analog)
MAM VENUS

Print article

Channels

Radiography

view channel
Image: The new machine algorithm can identify cardiovascular risk at the click of a button (Photo courtesy of Adobe Stock)

Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans

A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more

MRI

view channel
Image: In brains of control mice (left) and PD mice (right), from bottom to top: neuronal activity in a representative animal (Photo courtesy of Ruxanda Lungu/FC)

Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable

Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.